BJERKHOLT ERIC

SEC Form 4 insider
CHIEF FINANCIAL OFFICER · Mirum Pharmaceuticals, Inc. ($MIRM)
1 thesis · first seen Aug 12, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d
3d
1w
1m
3m
6m
1y

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$MIRMSEC Form 4bearish
Sold 9,943 @ $98.37 avg · $978,093 · 2026-09-14

Form 4: BJERKHOLT ERIC sold MIRM

BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc.) reported an open-market sale of 9,943 shares of MIRM at an average $98.37, roughly $978,093, in a Form 4 filed 2026-09-15.

At post $93.90Now $93.900.0% since postedas of Sep 15, 4:30 PM ET
View filing on SEC.gov →

End of results.